AssetMark’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
AssetMark's CAI Position: Q3 2026 in Review
AssetMark opened a new position in Caris Life Sciences (CAI) in Q3 2026: 87 shares worth $2.66K. The stake represents ﹤0.01% of the portfolio and ranks #2963 among its holdings.
252 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- AssetMark held 87 shares of Caris Life Sciences worth $2.66K as of Q3 2026.
- Caris Life Sciences was a new AssetMark position in Q3 2026.
- Caris Life Sciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2963 holding.
- 252 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.